Luis
Gandía Juan
Publicacións nas que colabora con Luis Gandía Juan (7)
2016
-
N-Benzylpiperidine Derivatives as α7 Nicotinic Receptor Antagonists
ACS Chemical Neuroscience, Vol. 7, Núm. 8, pp. 1157-1165
2011
-
Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3- carbonitriles
Bioorganic and Medicinal Chemistry, Vol. 19, Núm. 1, pp. 122-133
-
Synthesis, biological assessment and molecular modeling of new dihydroquinoline-3-carboxamides and dihydroquinoline-3-carbohydrazide derivatives as cholinesterase inhibitors, and Ca channel antagonists
European Journal of Medicinal Chemistry, Vol. 46, Núm. 1, pp. 1-10
2010
-
Computational analysis of the binding ability of heterocyclic and conformationally constrained epibatidine analogs in the neuronal nicotinic acetylcholine receptor
Molecular Diversity, Vol. 14, Núm. 2, pp. 201-211
-
Erratum: Computational analysis of the binding ability of heterocyclic and conformationally constrained epibatidine analogs in the neuronal nicotinic acetylcholine receptor (Mol Divers DOI: 10.1007/s11030-009-9161-9)
Molecular Diversity
-
Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles
Bioorganic and Medicinal Chemistry, Vol. 18, Núm. 16, pp. 5861-5872
2007
-
Neuroprotectant minocycline depresses glutamatergic neurotransmission and Ca2+ signalling in hippocampal neurons
European Journal of Neuroscience, Vol. 26, Núm. 9, pp. 2481-2495